Company

A new era for human health

Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

Purpose, strategy and culture

A signal for change

1:48

Close Video

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Purpose, strategy and culture

~1,700

are employed full time employees across Canada

At a glance

$2 bil +

invested in Canadian pharmaceutical and vaccines R&D since 2001

Innovation

$3 mil +

contributed over the last 20 years to support the hospice palliative care movement in Canada

Responsibility

GSK Global links

Visit our Global site for additional features

Creating a culture where individuals and teams thrive

Visit "At a glance" for details about our Canadian operations

Meet our outstanding people

Visit our global site to learn how our people are using their talents to work and innovate together

Global Behind the science magazine

See innovative stories to discover how we’re getting ahead

View all press releases

Follow @GSKCA on Twitter

Exciting opportunity for a remote, Bilingual Payroll Coordinator from anywhere Canada. Find out more #GSKCareers #BioPharma 👉gsk.to/3TKHMTSBO

Twitter @gskca Mar 26
Opportunité passionnante pour un(e) coordonnateur(trice) de la paie bilingue à distance de n'importe où au Canada. En savoir plus #GSKCareers #BioPharma gsk.to/3nhVBgmX7

Twitter @gskca Mar 26
We congratulate the Government of Canada on its announcement and plan for a National Strategy for Drugs for Rare Disease. These are important first steps towards addressing patient needs by improving access to life-altering screening, diagnosis and treatments for #rarediseases twitter.com/innovativemeds…

Twitter @gskca Mar 24
Attending the AMMI Canada – CACMID Annual Conference? Join @DrSamirSinha and @NelsonL_VirRes on March 29 at 4pm for the session titled Respiratory Syncytial Virus (RSV) in older adults: the under recognized burden, co-developed by GSK. See you there! gsk.to/3FEJmAQ

Twitter @gskca Mar 23
Vous assistez à la conférence annuelle de l'AMMI Canada - CACMID? Joignez-vous à @DrSamirSinha et @NelsonL_VirRes le 29 mars à 16h pour la session Respiratory Syncytial Virus (RSV) in older adults: the under recognized burden, co-développée par GSK. gsk.to/3z1WvjD

Twitter @gskca Mar 23
We congratulate the @GouvQc for including in its @FinancesQuebec @EricGirardMFQ budget announcement the coming addition of #shingles vaccination in the Quebec Immunization Program aligned with @INSPQ Quebec Immunization Committee recommendations 👏newswire.ca/news-releases/…i

Twitter @gskca Mar 21
Nous félicitons le @GouvQc d’inclure dans son budget @FinancesQuebec @EricGirardMFQ l’ajout prochain du vaccin contre le #zona dans le Programme québécois d’immunisation suivant ainsi les recommandations du Comité sur l’immunisation du Québec @INSPQ 👏newswire.ca/fr/news-releas…9

Twitter @gskca Mar 21
Meet Ramon Goomber who is part of our Pharmacy team at #GSKCanada helping to support #patientcare and access ⚕️ #GSKCareers #BioPharma

Twitter @gskca Mar 18
Faites la connaissance de Ramon Goomber, qui fait partie de notre équipe Pharmacie à #GSKCanada et qui aide à soutenir les #soinsauxpatients et l’accès ⚕️ #GSKCarrière #BioPharma

Twitter @gskca Mar 18
If you’re vacationing this #MarchBreak, make sure you learn more about which recommended or required vaccinations you’ll need to help stay healthy while at your destination before you take off gsk.to/3J9bg8MZH

Twitter @gskca Mar 10